filings.toolsItem 6. Exhibits
6K characters. Original on sec.gov · Markdown
Item 6. Exhibits
The exhibits listed in this Item 6 are filed as part of this Quarterly Report on Form 10-Q. Exhibits marked with an asterisk (*) are management contracts or compensatory plans or arrangements. Exhibits other than those listed are omitted because they are not required to be listed or are not applicable. Pursuant to Item 601(b)(4)(iii) of Regulation S-K, the Registrant hereby agrees to furnish to the U.S. Securities and Exchange Commission a copy of any omitted instrument that is not required to be listed.
INDEX TO EXHIBITS
| 10 | Material contracts | ||||
| 10.1* | Restrictive Covenant Agreement dated January 17, 2023 between the Registrant and Samrat Khichi. | ||||
| 10.2* | Change in Control Agreement effective as of February 20, 2023 between the Registrant and Samrat Khichi. | ||||
| 10.3 | Term Loan Credit Agreement, dated March 25, 2024, by and among the Registrant, the lenders party thereto and Bank of America, N.A., as administrative agent. | ||||
| 15 | Letter re: unaudited interim financial information | ||||
| 15.1 | Letter from Ernst & Young LLP acknowledging awareness of the use of a report dated March 31, 2024 related to their reviews of interim financial information. | ||||
| 31 | Rule 13a-14(a)/15d-14(a) Certifications | ||||
| 31.1 | Certification by the Chief Executive Officer. | ||||
| 31.2 | Certification by the Chief Financial Officer. | ||||
| 32 | Section 1350 Certifications | ||||
| 32.1 | Certification by the Chief Executive Officer. | ||||
| 32.2 | Certification by the Chief Financial Officer. | ||||
| 101 | |||||
| 101 | The following materials from the CVS Health Corporation Quarterly Report on Form 10-Q for the three months ended March 31, 2024 formatted in Inline XBRL: (i) the Condensed Consolidated Statements of Operations, (ii) the Condensed Consolidated Statements of Comprehensive Income, (iii) the Condensed Consolidated Balance Sheets, (iv) the Condensed Consolidated Statements of Cash Flows, (v) the Condensed Consolidated Statements of Shareholders’ Equity and (vi) the related Notes to Condensed Consolidated Financial Statements. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | ||||
| 104 | |||||
| 104 | Cover Page Interactive Data File - The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, formatted in Inline XBRL (included as Exhibit 101). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| CVS HEALTH CORPORATION | ||||||||
| Date: | May 1, 2024 | By: | /s/ Thomas F. Cowhey | ||||||||
| Thomas F. Cowhey | |||||||||||
| Executive Vice President and Chief Financial Officer | |||||||||||
Previous: Item 5. Other Information